Wegovy-maker Novo Nordisk to cut 9,000 jobs in restructuring
1. Novo Nordisk plans to cut 9,000 jobs to save $1.26 billion annually. 2. Restructuring aims to improve decision-making and resource allocation. 3. Operating profit growth forecast revised down to 4%-10% from 10%-16%. 4. Company faces increasing competition, especially from Eli Lilly in obesity drugs. 5. Stock value decreased 46% this year, now at $181 billion market cap.